SHH · 603439.SS
GuiZhou SanLi Pharmaceutical Co.,Ltd
CN¥10.61-CN¥0.13 (-1.21%)
GuiZhou SanLi Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.23% below the high.
Loading market information…
SHH · 688098.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shanghai Shen Lian Biomedical Corporation’s quoted price sits in the lower half of its reported 52-week range, 38.86% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Shanghai Shen Lian Biomedical Corporation’s forward annual dividend is CN¥0.04 per share, paid annual. The forward yield is 0.5% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shanghai Shen Lian Biomedical Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shanghai Shen Lian Biomedical Corporation operates within China's animal health industry, specializing in the entire lifecycle of veterinary biological products, from initial research and development to manufacturing and sales. A primary focus for the company is the creation of advanced synthetic peptide vaccines, specifically engineered to combat foot-and-mouth disease. This enterprise was established in 2001 and is based in Shanghai, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥10.61-CN¥0.13 (-1.21%)
GuiZhou SanLi Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 39.23% below the high.
CN¥13.00-CN¥0.20 (-1.52%)
Beijing Scitop Bio-tech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.99% below the high.
CN¥16.58-CN¥0.19 (-1.13%)
Hvsen Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.17% below the high.
CN¥9.21-CN¥0.44 (-4.56%)
Berry Genomics Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.07% below the high.
CN¥9.16-CN¥0.01 (-0.11%)
Pulike Biological Engineering, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.17% below the high.
CN¥16.09-CN¥0.64 (-3.83%)
Shanghai ZJ Bio-Tech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.7% below the high.
CN¥18.05-CN¥0.52 (-2.8%)
Lifecome Biochemistry Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 62.95% below the high.
CN¥15.53-CN¥0.32 (-2.02%)
Beijing Kawin Technology Share-Holding Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.07% below the high.
